.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In August 2026, Purefarma’s category mix concentrated 68.31% of sales in Oil with a month-over-month gain of 3.45% but a year-over-year decline of 11.06%, while Vapor Pens held 31.69% share with a steep month-over-month drop of 27.14% despite a year-over-year rise of 50.29%. Overall brand sales grew 2.16% year over year alongside a 1.43% average price decrease to $27.16, indicating that the Oil-led core is stabilizing month over month as Vapor Pens retrenched after prior expansion; the pattern implies near-term reliance on Oil for volume continuity while Vapor Pens contributes episodic upside rather than sustained share capture.
Positioning-wise, Purefarma’s rank of 8 in Oil in British Columbia combined with a 3.45% month-over-month Oil lift versus a 27.14% month-over-month decline in Vapor Pens suggests the brand competes on consistency in its lead category rather than on breadth. With 24-month brand sales down 30.58% but August 2026 year-over-year sales up 2.16%, and Oil still at 68.31% share versus 31.69% for Vapor Pens, the implication is that recovery depends on deepening Oil penetration at current price points while pacing Vapor Pen promotions to avoid volatility-driven share swings.
Competitive Landscape
Purefarma holds rank #8 in BC Oil in August 2026 with no year-over-year rank change from #8, and no three-month change from #8, while its peak of #6 in November 2025 marks a two-spot slide since that high. Competitors are moving differently: NightNight climbed from #5 to #3 alongside a 27.6% YoY sales increase, whereas MediPharm Labs improved its rank from #6 to #5 despite a 3.3% YoY sales decline; at the top, Glacial Gold stayed #1 with a 3.7% YoY lift and Pura Vida held #2 with a 1.5% YoY gain. The pattern implies Purefarma’s flat rank through August 2026, coupled with a two-rank drop from its November 2025 peak and competitors’ upward or stabilized moves, signals a plateau that risks gradual share erosion unless trajectory shifts.
Notable Products
CBD Hemplixir 30 Oil (30ml) posted the standout move in August 2026 with +183% month-over-month and a jump to rank 1, eclipsing the steep -27% slide for CBD Earth Full Spectrum Cartridge (1g) at rank 2. CBD 100 Hemplixir Oil (30ml) gained +8% while holding rank 3, and with two of the top three positions occupied by Oil SKUs, the category concentration suggests margin and supply prioritization toward tinctures over cartridges. The $22,615 in August 2026 sales for CBD Hemplixir 30 Oil (30ml), combined with its pace-setting rank 1 vs. the cartridge’s rank 2 decline, indicates a pivot to wellness-oriented formats and away from inhalables in Purefarma’s near-term product strategy.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
